Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Diabetes & Endocrinology

Topics

Chemistry

Biochemistry

Medicine

Internal Medicine

Endocrinology

Show all topics

DOI

10.1016/s2213-8587(18)30071-8

License

CC-BY

Other Formats

PDF